Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-effect clinical pharmacology study of K-237 in healthy adult volunteers
jRCT2071210085Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ursodeoxycholic acid in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Kowa Company, Ltd. Primary endpoint: Adverse events and adverse drug reactions. Started Oct 2021; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2071210085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210085.